Page last updated: 2024-10-17

dihydrolipoic acid and Leucocythaemia

dihydrolipoic acid has been researched along with Leucocythaemia in 1 studies

dihydrolipoic acid: RN given refers to parent cpd without isomeric designation
dihydrolipoic acid : A thio-fatty acid that is reduced form of lipoic acid. A potent antioxidant shown to directly destroy superoxide, hydroperoxy and hydroxyl radicals; also has neuroprotective and anti-tumour effects.
dihydrolipoate : The conjugate base of dihydrolipoic acid.

Research Excerpts

ExcerptRelevanceReference
"Etoposide (VP-16) is an antitumor drug currently in use for the treatment of a number of human cancers."1.29Tyrosinase-induced phenoxyl radicals of etoposide (VP-16): interaction with reductants in model systems, K562 leukemic cell and nuclear homogenates. ( Gantchev, T; Kagan, V; Stoyanovsky, D; Yalowich, J, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stoyanovsky, D1
Yalowich, J1
Gantchev, T1
Kagan, V1

Other Studies

1 other study available for dihydrolipoic acid and Leucocythaemia

ArticleYear
Tyrosinase-induced phenoxyl radicals of etoposide (VP-16): interaction with reductants in model systems, K562 leukemic cell and nuclear homogenates.
    Free radical research communications, 1993, Volume: 19, Issue:6

    Topics: Ascorbic Acid; Cell Nucleus; Chromatography, High Pressure Liquid; Deferoxamine; Electron Spin Reson

1993